{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:57:48Z","timestamp":1781517468357,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,2]],"date-time":"2016-05-02T00:00:00Z","timestamp":1462147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.diabres.2016.04.046","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T14:04:13Z","timestamp":1462457053000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Improved diastolic function in type 2 diabetes after a six month liraglutide treatment"],"prefix":"10.1016","volume":"118","author":[{"given":"Fabio","family":"Saponaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Sonaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Montefusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Adda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2016.04.046_b0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-2840-13-59","volume":"13","author":"Pugliese","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2016.04.046_b0010","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0015","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.amjcard.2009.01.358","article-title":"Changes in diastolic dysfunction in diabetes mellitus over time","volume":"103","author":"From","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2016.04.046_b0025","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1210\/er.2003-0012","article-title":"Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"25","author":"Fang","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.diabres.2016.04.046_b0030","first-page":"630537","article-title":"Glucagon-like peptide-1 analog liraglutide protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway","author":"Liu","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.diabres.2016.04.046_b0035","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3892\/mmr.2014.1956","article-title":"Liraglutide alleviates diabetic cardiomyopathy by blocking CHOP-triggered apoptosis via the inhibition of IRE-\u03b1 pathway","volume":"9","author":"Ji","year":"2014","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.diabres.2016.04.046_b0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1262-3636(07)70059-9","article-title":"Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy?","volume":"29","author":"Cosson","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2016.04.046_b0045","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000064682","article-title":"Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy","volume":"98","author":"Schannwell","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.diabres.2016.04.046_b0055","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ahj.2010.06.040","article-title":"Diastolic dysfunction: improved understanding using emerging imaging techniques","volume":"160","author":"Daneshvar","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2016.04.046_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0033-0620(90)90017-V","article-title":"Clinical evaluation of left ventricular diastolic performance","volume":"32","author":"Littel","year":"1990","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2016.04.046_b0065","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.102.15.1788","article-title":"Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study","volume":"102","author":"Ommen","year":"2000","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.diabres.2016.04.046_b0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","article-title":"The safety and efficacy of liraglutide with or without oral antidiabetic drugs therapy in type 2 diabetes: an overview of the LEAD 1\u20135 studies","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2016.04.046_b0075","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2010.11.002","article-title":"Incretin-based therapies for type 2 diabetes mellitus: properties, functions, and clinical implications","volume":"124","author":"Nauck","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.diabres.2016.04.046_b0080","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.2337\/dc06-2593","article-title":"Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes","volume":"30","author":"Vilsboll","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2016.04.046_b0085","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2016.04.046_b0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2008.02484.x","article-title":"Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with type 2 diabetes","volume":"25","author":"Courr\u00e8ges","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2016.04.046_b0095","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","article-title":"Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences","volume":"358","author":"Wei","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.diabres.2016.04.046_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/1755-5922.12000","article-title":"GLP-1 receptor agonists: effects on cardiovascular risk reduction","volume":"31","author":"Lorber","year":"2013","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.diabres.2016.04.046_b0105","first-page":"A612","article-title":"Liraglutide effects and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial: rationale and study design","volume":"60","author":"Mannucci","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2016.04.046_b0110","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.regpep.2007.10.001","article-title":"Protective effects of GLP-1 analogue exendine-4 and GLP-1 (9\u201336) amide against ischemia-reperfusion injury in rat heart","volume":"146","author":"Sonne","year":"2008","journal-title":"Regul Pept"},{"key":"10.1016\/j.diabres.2016.04.046_b0115","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1161\/01.CIR.0000120505.91348.58","article-title":"Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion","volume":"109","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2016.04.046_b0120","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.amjcard.2007.05.022","article-title":"Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting","volume":"100","author":"Sokos","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0125","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","article-title":"Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure","volume":"12","author":"Sokos","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.diabres.2016.04.046_b0130","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2016.04.046_b0135","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-s064","article-title":"Diagnosis and classification of diabetes mellitus","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2016.04.046_b0140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/ejechocard\/jep007","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"10","author":"Nagueh","year":"2009","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.diabres.2016.04.046_b0145","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2011.01.015","article-title":"Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE\/EAE consensus statement on methodology and indications endorsed by the Japanese society of echocardiography","volume":"24","author":"Mor-Avi","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.diabres.2016.04.046_b0150","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0735-1097(96)00496-2","article-title":"An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure","volume":"29","author":"Garcia","year":"1997","journal-title":"J Am Coll Card"},{"key":"10.1016\/j.diabres.2016.04.046_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1475-2840-9-63","article-title":"Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study","volume":"9","author":"Dinh","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabres.2016.04.046_b0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2016.04.046_b0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402","article-title":"Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure prone rat","volume":"1","author":"Poornima","year":"2008","journal-title":"Circ Heart Fail"},{"issue":"2","key":"10.1016\/j.diabres.2016.04.046_b0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/er.2011-1052","article-title":"Cardiovascular biology of the incretin system","volume":"33","author":"Ussher","year":"2012","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.diabres.2016.04.046_b0175","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jdi.12065","article-title":"Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: incretin actions beyond the pancreas","volume":"4","author":"Seino","year":"2013","journal-title":"J Diab Invest"},{"key":"10.1016\/j.diabres.2016.04.046_b0180","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1007\/s00125-011-2440-x","article-title":"Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double blind, randomised controlled clinical trial of efficacy and safety","volume":"55","author":"Best","year":"2012","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.diabres.2016.04.046_b0185","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jdiacomp.2014.01.009","article-title":"A meta-analysis of six clinical trials demonstrates that the once-daily human GLP-1 analogue liraglutide reduces systolic blood pressure","volume":"28","author":"Fonseca","year":"2014","journal-title":"J Diab Compl"},{"key":"10.1016\/j.diabres.2016.04.046_b0190","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.diabres.2015.07.015","article-title":"Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"110","author":"Sun","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2016.04.046_b0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jcmg.2010.05.011","article-title":"Assessment of subendocardial structure and function","volume":"3","author":"Stanton","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.diabres.2016.04.046_b0200","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0002-9149(96)00033-1","article-title":"Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function","volume":"77","author":"Gulati","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0205","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0894-7317(99)70145-8","article-title":"Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation","volume":"12","author":"Sohn","year":"1999","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.diabres.2016.04.046_b0210","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.amjcard.2006.04.044","article-title":"Differences of lateral and septal mitral annulus velocity by tissue Doppler imaging in the evaluation of left ventricular diastolic function","volume":"98","author":"Park","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0215","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jacc.2007.01.078","article-title":"Tissue Doppler imaging: a new prognosticator for cardiovascular diseases","volume":"49","author":"Yu","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0220","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jacc.2004.09.059","article-title":"Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function","volume":"45","author":"Wang","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diabres.2016.04.046_b0225","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi","year":"2014","journal-title":"J Card Fail"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822716301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T09:35:13Z","timestamp":1567848913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822716301103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":45,"alternative-id":["S0168822716301103"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2016.04.046","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved diastolic function in type 2 diabetes after a six month liraglutide treatment","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2016.04.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}